Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last ¥1,080 JPY
Change Today +8.00 / 0.75%
Volume 20.6K
4570 On Other Exchanges
Symbol
Exchange
Tokyo
As of 2:00 AM 04/21/15 All times are local (Market data is delayed by at least 15 minutes).

immuno-biological laboratori (4570) Snapshot

Open
¥1,067
Previous Close
¥1,072
Day High
¥1,081
Day Low
¥1,066
52 Week High
04/1/15 - ¥1,388
52 Week Low
05/21/14 - ¥860.00
Market Cap
7.1B
Average Volume 10 Days
19.7K
EPS TTM
¥-19.97
Shares Outstanding
6.5M
EX-Date
03/27/15
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for IMMUNO-BIOLOGICAL LABORATORI (4570)

Related News

No related news articles were found.

immuno-biological laboratori (4570) Related Businessweek News

No Related Businessweek News Found

immuno-biological laboratori (4570) Details

Immuno-Biological Laboratories Co., Ltd. provides various medicines and in-vitro diagnostic products used to promote the fight against diseases in Japan. It develops antibodies against proteins related to intractable diseases, such as cancers, autoimmune diseases, and disorders of the brain and nervous system; and manufactures diagnostic tests that make the use of antibodies. The company also offers various reagents, such as antibodies for alzheimer's disease, osteopontin, immunoglobulins, immunohistochemistry, cancer research, cytokines, and other research; EIA kits that assay target proteins by using the antigen antibody reaction; and proteins. In addition, it develops various transgenic animal models; and provides antibody drug candidates, as well as offers custom services on crossbreeding with other transgenic mice and the function analysis of those animals. Further, the company manufactures AsthNon 3000, a soft water drink that is used as a sports supplement to improve moving ability. It markets its products through a network of distributors and dealers in the United States and Europe. Immuno-Biological Laboratories Co., Ltd. was founded in 1982 and is headquartered in Fujioka, Japan.

52 Employees
Last Reported Date: 06/27/14
Founded in 1982

immuno-biological laboratori (4570) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

immuno-biological laboratori (4570) Key Developments

Immuno-Biological Laboratories Co., Ltd. to Report Q3, 2015 Results on Feb 06, 2015

Immuno-Biological Laboratories Co., Ltd. announced that they will report Q3, 2015 results on Feb 06, 2015

Immuno-Biological Laboratories Co., Ltd., Q2 2015 Earnings Call, Nov 20, 2014

Immuno-Biological Laboratories Co., Ltd., Q2 2015 Earnings Call, Nov 20, 2014

Immuno-Biological Laboratories Co., Ltd. to Report Q2, 2015 Results on Nov 07, 2014

Immuno-Biological Laboratories Co., Ltd. announced that they will report Q2, 2015 results on Nov 07, 2014

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
4570:JP ¥1,080.00 JPY +8.00

4570 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 4570.
View Industry Companies
 

Industry Analysis

4570

Industry Average

Valuation 4570 Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 10.6x
Price/Book 2.7x
Price/Cash Flow NM Not Meaningful
TEV/Sales 8.0x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact IMMUNO-BIOLOGICAL LABORATORI, please visit www.ibl-japan.co.jp. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.